ABSTRACT: Serum levels of Angiopoietin-2 (Ang-2) and C-reactive protein (CRP) were measured in 50 patients with chronic myeloid leukemia (CML) (30 patients in chronic phase (group A) and 20 patients in advanced phase (group B)) and 15 healthy age and sex matched subjects as a control group, to investigate their relation to different phases of the disease. Serum levels of both Ang-2 and CRP were significantly higher (p<0.05) in patients group compared to controls, and in advanced stage compared to chronic phase. Furthermore a significant positive correlation was detected between Ang-2 and CRP in the whole patients group which could support the hypothesis that CRP might play a role in modulating angiogenesis. The present data suggest that both Ang-2 and CRP could play a role in the leukemic process. Understanding their roles may help in follow-up care and in designing new therapeutic strategies for CML. Furthermore, the role of CRP in modulating angiogenesis should not be underestimated.
INTRODUCTION
The aim of the present work was to study the serum level of Ang-2 and CRP in chronic myeloid leukemia patients, and their relation to different phases of the disease, also to investigate the angiogenic properties of CRP and to find out if there is any correlation between these two parameters.
PATIENTS AND METHODS
The present study included 65 subjects 
Statistical methods:
Statistical analysis was done using SPSS program" version 17"(Statistical Package of social sciences, Chicago, USA) observed when comparing patients group to control group and when comparing group A to group B (table 2) .
RESULTS

Spleen size and serum levels of Ang-2 and CRP in patients:
When subdividing all CML patients according to spleen size it was found that, in the chronic phase, 16 patients showed mild (53.3%), 8 patients showed moderate (26.7%) and 6 patients showed huge splenomegaly (20%). In the accelerated and crisis phases, 6 patients showed moderate (30%) and 14 patients showed huge splenomegaly (70%).
Median Ang-2 and CRP serum levels showed statistically significant difference among patients with different spleen size (table 3) .
Correlations between serum levels of
Ang-2 and CRP in patients: (18) who found significant associations between plasma VEGF and enlarged spleens. In contrast, yerstovesk et al. (14) reported that the level of VEGF expression correlated inversely with the degree of splenomegaly.
In the present study a statistically significant positive correlation was detected between serum Ang-2 level and blast percentages in the bone marrow. These findings are in accordance with the findings of Liu et al. (18) who reported significant association between plasma VEGF and blast percentage in chronic myeloid leukaemia.
As regard C-reactive protein, a statistically significant higher level was found in CML patients compared to controls, and in patients with advanced stage compared to those with chronic phase. These results are in accordance with the study of Akanni et al. (19) who showed that CRP level was significantly higher in the CML patients when compared to the controls. They attributed this to the rise in plasma concentration of interleukin-6 which is produced predominantly by the macrophages. (7) Also, Humlová et al. (20) reported increased serum levels of CRP in 
